| [1] |
Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases[J]. Nat Rev Dis Primers, 2017, 3: 17038.
doi: 10.1038/nrdp.2017.38
pmid: 28805207
|
| [2] |
Sanz M, Marco Del Castillo A, Jepsen S, et al. Periodontitis and cardiovascular diseases: Consensus report[J]. J Clin Periodontol, 2020, 47(3): 268-288.
doi: 10.1111/jcpe.13189
pmid: 32011025
|
| [3] |
段胜仲. 牙周微生态与心脑血管疾病研究进展[J]. 口腔医学, 2021, 41(7): 577-582.
|
| [4] |
Ruan QJ, Guan P, Qi WJ, et al. Porphyromonas gingivalis regulates atherosclerosis through an immune pathway[J]. Front Immunol, 2023, 14: 1103592.
|
| [5] |
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis[J]. Nature, 2011, 473(7347): 317-325.
|
| [6] |
Singh V, Kaur R, Kumari P, et al. ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders[J]. Clin Chim Acta, 2023, 548: 117487.
|
| [7] |
Simons KH, Jong AD, Jukema JW, et al. T cell co-stimulation and co-inhibition in cardiovascular disease: A double-edged sword[J]. Nat Rev Cardiol, 2019, 16(6): 325-343.
doi: 10.1038/s41569-019-0164-7
pmid: 30770894
|
| [8] |
Kanno T, Nakajima T, Miyako K, et al. Lipid metabolism in Th17 cell function[J]. Pharmacol Ther, 2023, 245: 108411.
|
| [9] |
Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases[J]. Semin Immunopathol, 2019, 41(3): 283-297.
doi: 10.1007/s00281-019-00733-8
pmid: 30891627
|
| [10] |
Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance[J]. Cell, 2008, 133(5): 775-787.
doi: 10.1016/j.cell.2008.05.009
pmid: 18510923
|
| [11] |
He X, Liang B, Gu N. Th17/treg imbalance and atherosclerosis[J]. Dis Markers, 2020, 2020: 8821029.
|
| [12] |
Yang J, Wu J, Zhang R, et al. Porphyromonas gingivalis oral infection promote T helper 17/Treg imbalance in the development of atherosclerosis[J]. J Dent Sci, 2017, 12(1): 60-69.
doi: 10.1016/j.jds.2016.10.003
pmid: 30895025
|
| [13] |
Shen H, Jiang YT, Qiu C, et al. Abnormal amyloid precursor protein processing in periodontal tissue in a murine model of periodontitis induced by Porphyromonas gingivalis[J]. J Periodontal Res, 2024, 59(2): 395-407.
doi: 10.1111/jre.13224
pmid: 38311599
|
| [14] |
Wu Q, Li Z, Zhang Y, et al. Cyclic di-AMP rescues Porphyromonas gingivalis-aggravated atherosclerosis[J]. J Dent Res, 2023, 102(7): 785-794.
|
| [15] |
Reyes L. Porphyromonas gingivalis[J]. Trends Microbiol, 2021, 29(4): 376-377.
doi: 10.1016/j.tim.2021.01.010
pmid: 33546976
|
| [16] |
Mulhall H, Huck O, Amar S. Porphyromonas gingivalis, a long-range pathogen: Systemic impact and therapeutic implications[J]. Microorganisms, 2020, 8(6): 869.
|
| [17] |
Xu X, Chen F, Huang ZW, et al. Meeting report: A close look at oral biofilms and microbiomes[J]. Int J Oral Sci, 2018, 10(3): 28.
doi: 10.1038/s41368-018-0030-1
pmid: 30111787
|
| [18] |
Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque[J]. J Clin Periodontol, 1998, 25(2): 134-144.
doi: 10.1111/j.1600-051x.1998.tb02419.x
pmid: 9495612
|
| [19] |
Miller DP, Wang Q, Weinberg A, et al. Transcriptome analysis of Porphyromonas gingivalis and Acinetobacter baumannii in polymicrobial communities[J]. Mol Oral Microbiol, 2018, 33(5): 364-377.
doi: 10.1111/omi.12238
pmid: 29939498
|
| [20] |
Meuric V, Le Gall-David S, Boyer E, et al. Signature of microbial dysbiosis in periodontitis[J]. Appl Environ Microbiol, 2017, 83(14): e00462-17.
|
| [21] |
Minty M, Canceil T, Serino M, et al. Oral microbiota-induced periodontitis: A new risk factor of metabolic diseases[J]. Rev Endocr Metab Disord, 2019, 20(4): 449-459.
|
| [22] |
钱泉, 刘银辉. 口腔微生物在牙周健康中的作用研究进展[J]. 中国微生态学杂志, 2025, 37(2): 228-232, 239.
|
| [23] |
Baker JL, Mark Welch JL, Kauffman KM, et al. The oral microbiome: Diversity, biogeography and human health[J]. Nat Rev Microbiol, 2024, 22(2): 89-104.
|
| [24] |
Herrero-Fernandez B, Gomez-Bris R, Somovilla-Crespo B, et al. Immunobiology of atherosclerosis: A complex net of interactions[J]. Int J Mol Sci, 2019, 20(21): 5293.
|
| [25] |
Xue JJ, Zhang ZW, Sun YT, et al. Research progress and molecular mechanisms of endothelial cells inflammation in vascular-related diseases[J]. J Inflamm Res, 2023, 16: 3593-3617.
doi: 10.2147/JIR.S418166
pmid: 37641702
|
| [26] |
Liu XR, Xu Q, Xiao J, et al. Role of oral microbiota in atherosclerosis[J]. Clin Chim Acta, 2020, 506: 191-195.
|
| [27] |
袁芸, 张洪铭, 黄慧. 牙周炎对大鼠外周血中辅助性T细胞分群的影响[J]. 上海交通大学学报(医学版), 2020, 40(10): 1360-1364.
|
| [28] |
Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities[J]. Nat Rev Immunol, 2021, 21(7): 426-440.
doi: 10.1038/s41577-020-00488-6
pmid: 33510490
|
| [29] |
Robert M, Miossec P, Hot A. The Th17 pathway in vascular inflammation: Culprit or consort?[J]. Front Immunol, 2022, 13: 888763.
|
| [30] |
Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis[J]. Nat Rev Cardiol, 2020, 17(7): 387-401.
doi: 10.1038/s41569-020-0352-5
pmid: 32203286
|
| [31] |
Peng X, Cheng L, You Y, et al. Oral microbiota in human systematic diseases[J]. Int J Oral Sci, 2022, 14(1): 14.
doi: 10.1038/s41368-022-00163-7
pmid: 35236828
|
| [32] |
Hector A, Schäfer H, Pöschel S, et al. Regulatory T-cell impairment in cystic fibrosis patients with chronic Pseudomonas infection[J]. Am J Respir Crit Care Med, 2015, 191(8): 914-923.
|
| [33] |
Villeret B, Ghinnagow R, Kheir S, et al. Pseudomonas aeruginosa lung infection subverts lymphocytic responses through IL-23 and IL-22 post-transcriptional regulation[J]. Int J Mol Sci, 2022, 23(15): 8427.
|
| [34] |
Cekanaviciute E, Yoo BB, Runia TF, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models[J]. Proc Natl Acad Sci USA, 2017, 114(40): 10713-10718.
doi: 10.1073/pnas.1711235114
pmid: 28893978
|
| [35] |
Meyer CU, Zepp F. Principles in immunology for the design and development of vaccines[J]. Methods Mol Biol, 2022, 2410: 27-56.
doi: 10.1007/978-1-0716-1884-4_2
pmid: 34914041
|